Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Solitary Pulmonary Nodule | 13 | 2024 | 282 | 5.550 |
Why?
|
Multiple Pulmonary Nodules | 13 | 2024 | 175 | 5.170 |
Why?
|
Tomography, X-Ray Computed | 64 | 2024 | 20762 | 4.590 |
Why?
|
Lung Neoplasms | 34 | 2024 | 13586 | 4.190 |
Why?
|
Early Detection of Cancer | 20 | 2024 | 3239 | 2.900 |
Why?
|
Radiography, Thoracic | 11 | 2024 | 1321 | 2.360 |
Why?
|
Lung Diseases | 7 | 2022 | 1944 | 1.650 |
Why?
|
Incidental Findings | 4 | 2024 | 698 | 1.420 |
Why?
|
Pulmonary Embolism | 7 | 2024 | 2599 | 1.420 |
Why?
|
Thymus Neoplasms | 3 | 2023 | 274 | 1.400 |
Why?
|
Lung | 21 | 2024 | 10101 | 1.250 |
Why?
|
Precancerous Conditions | 4 | 2022 | 985 | 1.180 |
Why?
|
Mucormycosis | 2 | 2018 | 102 | 1.110 |
Why?
|
Diaphragm | 2 | 2017 | 357 | 0.880 |
Why?
|
Retrospective Studies | 42 | 2024 | 81760 | 0.830 |
Why?
|
Mediastinal Cyst | 1 | 2022 | 30 | 0.820 |
Why?
|
Fibroma | 1 | 2024 | 197 | 0.810 |
Why?
|
Pneumonia | 4 | 2023 | 2163 | 0.800 |
Why?
|
Pneumonia, Viral | 7 | 2020 | 3238 | 0.780 |
Why?
|
Pleural Effusion | 2 | 2022 | 344 | 0.770 |
Why?
|
Thoracic Neoplasms | 1 | 2024 | 269 | 0.770 |
Why?
|
Chylothorax | 1 | 2022 | 83 | 0.770 |
Why?
|
Carcinoid Tumor | 1 | 2023 | 225 | 0.740 |
Why?
|
Thoracic Diseases | 2 | 2019 | 99 | 0.730 |
Why?
|
Thymoma | 1 | 2022 | 188 | 0.720 |
Why?
|
Lymphatic Abnormalities | 1 | 2022 | 134 | 0.720 |
Why?
|
Lung Diseases, Fungal | 2 | 2019 | 124 | 0.720 |
Why?
|
Hamartoma | 1 | 2023 | 236 | 0.710 |
Why?
|
Bronchiectasis | 1 | 2022 | 141 | 0.710 |
Why?
|
Wounds, Nonpenetrating | 3 | 2015 | 807 | 0.670 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2023 | 342 | 0.630 |
Why?
|
Diagnosis, Differential | 13 | 2024 | 13013 | 0.610 |
Why?
|
Humans | 96 | 2024 | 768171 | 0.610 |
Why?
|
Radiology, Interventional | 1 | 2022 | 483 | 0.600 |
Why?
|
Decision Making, Computer-Assisted | 1 | 2018 | 146 | 0.600 |
Why?
|
Torsion Abnormality | 1 | 2017 | 92 | 0.570 |
Why?
|
Immunocompromised Host | 2 | 2019 | 863 | 0.550 |
Why?
|
Klippel-Trenaunay-Weber Syndrome | 1 | 2017 | 69 | 0.550 |
Why?
|
Hypertrophy, Right Ventricular | 1 | 2017 | 109 | 0.540 |
Why?
|
Leukemia, Myeloid | 1 | 2019 | 693 | 0.530 |
Why?
|
Aged | 37 | 2024 | 171502 | 0.530 |
Why?
|
Catheterization, Central Venous | 1 | 2021 | 537 | 0.530 |
Why?
|
Radiology | 5 | 2023 | 2104 | 0.530 |
Why?
|
Radiology Department, Hospital | 1 | 2020 | 409 | 0.530 |
Why?
|
Bacterial Typing Techniques | 1 | 2017 | 263 | 0.520 |
Why?
|
Calcinosis | 2 | 2022 | 1482 | 0.510 |
Why?
|
Mediastinal Neoplasms | 1 | 2019 | 403 | 0.510 |
Why?
|
Hypothyroidism | 1 | 2021 | 667 | 0.510 |
Why?
|
Liver Abscess | 1 | 2015 | 81 | 0.500 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2019 | 489 | 0.490 |
Why?
|
Herpes Simplex | 1 | 2018 | 470 | 0.490 |
Why?
|
Search Engine | 1 | 2016 | 142 | 0.490 |
Why?
|
Evolution, Molecular | 1 | 2023 | 1896 | 0.470 |
Why?
|
Wounds, Penetrating | 2 | 2015 | 316 | 0.470 |
Why?
|
Rib Fractures | 1 | 2015 | 124 | 0.460 |
Why?
|
Magnetic Resonance Imaging | 8 | 2024 | 36741 | 0.460 |
Why?
|
Thyroid Nodule | 1 | 2021 | 767 | 0.460 |
Why?
|
Coronavirus Infections | 6 | 2020 | 3115 | 0.450 |
Why?
|
Middle Aged | 35 | 2024 | 223487 | 0.450 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2019 | 498 | 0.450 |
Why?
|
Aneurysm | 1 | 2017 | 343 | 0.440 |
Why?
|
Aged, 80 and over | 18 | 2024 | 59626 | 0.430 |
Why?
|
Male | 42 | 2024 | 364731 | 0.410 |
Why?
|
Imaging, Three-Dimensional | 2 | 2024 | 4064 | 0.410 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2016 | 594 | 0.410 |
Why?
|
Female | 44 | 2024 | 397187 | 0.400 |
Why?
|
Pericarditis | 1 | 2013 | 136 | 0.400 |
Why?
|
Diagnostic Errors | 1 | 2019 | 1281 | 0.400 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2018 | 1232 | 0.380 |
Why?
|
Venous Thrombosis | 1 | 2021 | 1321 | 0.370 |
Why?
|
Observer Variation | 4 | 2024 | 2621 | 0.370 |
Why?
|
Communicable Diseases | 1 | 2019 | 873 | 0.370 |
Why?
|
Lung Injury | 1 | 2015 | 433 | 0.360 |
Why?
|
Diagnostic Tests, Routine | 1 | 2016 | 789 | 0.350 |
Why?
|
Algorithms | 4 | 2020 | 14164 | 0.350 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2017 | 843 | 0.340 |
Why?
|
Adult | 25 | 2024 | 223646 | 0.340 |
Why?
|
Guideline Adherence | 1 | 2020 | 2235 | 0.340 |
Why?
|
Medical Informatics | 1 | 2016 | 743 | 0.320 |
Why?
|
Coronavirus | 2 | 2020 | 156 | 0.290 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2022 | 3251 | 0.290 |
Why?
|
Heart Valve Diseases | 1 | 2015 | 1030 | 0.290 |
Why?
|
Forecasting | 1 | 2016 | 2945 | 0.280 |
Why?
|
Reproducibility of Results | 7 | 2024 | 20225 | 0.280 |
Why?
|
Sensitivity and Specificity | 5 | 2024 | 14729 | 0.260 |
Why?
|
Hypertension, Pulmonary | 1 | 2017 | 1605 | 0.260 |
Why?
|
Mass Screening | 4 | 2023 | 5458 | 0.250 |
Why?
|
Mycobacterium tuberculosis | 1 | 2017 | 1930 | 0.250 |
Why?
|
Kidney Diseases | 1 | 2016 | 2100 | 0.250 |
Why?
|
Practice Guidelines as Topic | 2 | 2020 | 7454 | 0.240 |
Why?
|
Research Design | 2 | 2020 | 6209 | 0.240 |
Why?
|
Patient Selection | 1 | 2017 | 4260 | 0.240 |
Why?
|
Fluorodeoxyglucose F18 | 3 | 2023 | 2055 | 0.240 |
Why?
|
Quality-Adjusted Life Years | 2 | 2021 | 1741 | 0.230 |
Why?
|
Evidence-Based Medicine | 1 | 2016 | 3706 | 0.230 |
Why?
|
Wounds and Injuries | 1 | 2017 | 2517 | 0.230 |
Why?
|
Internet | 1 | 2016 | 3110 | 0.230 |
Why?
|
Cost-Benefit Analysis | 3 | 2021 | 5536 | 0.220 |
Why?
|
Young Adult | 10 | 2024 | 60066 | 0.220 |
Why?
|
Artifacts | 2 | 2024 | 1926 | 0.210 |
Why?
|
Follow-Up Studies | 6 | 2023 | 39354 | 0.210 |
Why?
|
Echocardiography | 1 | 2015 | 5047 | 0.210 |
Why?
|
Coronary Artery Disease | 1 | 2022 | 6568 | 0.210 |
Why?
|
Risk Assessment | 3 | 2020 | 24318 | 0.200 |
Why?
|
Mycobacterium avium Complex | 1 | 2022 | 66 | 0.200 |
Why?
|
Internship and Residency | 1 | 2022 | 5953 | 0.200 |
Why?
|
Thoracic Duct | 1 | 2022 | 71 | 0.200 |
Why?
|
Abdominal Cavity | 1 | 2022 | 34 | 0.200 |
Why?
|
Lymphography | 1 | 2022 | 189 | 0.190 |
Why?
|
Predictive Value of Tests | 4 | 2020 | 15453 | 0.190 |
Why?
|
Contrast Media | 4 | 2024 | 5330 | 0.190 |
Why?
|
Acute Disease | 3 | 2024 | 7243 | 0.180 |
Why?
|
Radiography | 4 | 2024 | 6986 | 0.170 |
Why?
|
Delayed Diagnosis | 2 | 2024 | 467 | 0.170 |
Why?
|
Thoracic Wall | 1 | 2022 | 204 | 0.170 |
Why?
|
Liver | 1 | 2015 | 7578 | 0.170 |
Why?
|
Bronchi | 1 | 2024 | 850 | 0.170 |
Why?
|
Esophagectomy | 1 | 2023 | 481 | 0.170 |
Why?
|
Leukemic Infiltration | 1 | 2019 | 47 | 0.170 |
Why?
|
Paraneoplastic Endocrine Syndromes | 1 | 2019 | 29 | 0.170 |
Why?
|
Heart Neoplasms | 1 | 2023 | 374 | 0.170 |
Why?
|
Acute Lung Injury | 1 | 2023 | 378 | 0.160 |
Why?
|
Adolescent | 8 | 2024 | 89169 | 0.160 |
Why?
|
Severe Acute Respiratory Syndrome | 1 | 2020 | 136 | 0.160 |
Why?
|
Neoplasms, Neuroepithelial | 1 | 2019 | 42 | 0.160 |
Why?
|
Digestive System Abnormalities | 1 | 2019 | 49 | 0.160 |
Why?
|
Pandemics | 6 | 2020 | 8747 | 0.160 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 5432 | 0.160 |
Why?
|
Choriocarcinoma | 1 | 2019 | 121 | 0.160 |
Why?
|
Syringomyelia | 1 | 2019 | 67 | 0.160 |
Why?
|
Dermoid Cyst | 1 | 2019 | 92 | 0.150 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2020 | 425 | 0.150 |
Why?
|
Pleural Neoplasms | 1 | 2023 | 612 | 0.150 |
Why?
|
Paraneoplastic Syndromes | 1 | 2019 | 154 | 0.150 |
Why?
|
North America | 1 | 2021 | 1289 | 0.150 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2023 | 646 | 0.140 |
Why?
|
Mediastinum | 1 | 2019 | 272 | 0.140 |
Why?
|
Sacrum | 1 | 2019 | 274 | 0.140 |
Why?
|
Decision Trees | 1 | 2019 | 508 | 0.140 |
Why?
|
Prevalence | 5 | 2023 | 15869 | 0.140 |
Why?
|
Mesothelioma | 1 | 2023 | 811 | 0.140 |
Why?
|
Ossification, Heterotopic | 1 | 2019 | 240 | 0.130 |
Why?
|
Anal Canal | 1 | 2019 | 376 | 0.130 |
Why?
|
Soft Tissue Neoplasms | 1 | 2024 | 1164 | 0.120 |
Why?
|
Opportunistic Infections | 1 | 2018 | 375 | 0.120 |
Why?
|
Rectum | 1 | 2019 | 900 | 0.110 |
Why?
|
Documentation | 1 | 2021 | 917 | 0.110 |
Why?
|
Iatrogenic Disease | 1 | 2017 | 552 | 0.110 |
Why?
|
Triiodobenzoic Acids | 1 | 2013 | 123 | 0.110 |
Why?
|
Risk Factors | 5 | 2024 | 74944 | 0.110 |
Why?
|
Access to Information | 1 | 2016 | 317 | 0.110 |
Why?
|
Esophageal Neoplasms | 1 | 2023 | 1668 | 0.110 |
Why?
|
Pneumonectomy | 1 | 2020 | 1156 | 0.110 |
Why?
|
Peritoneal Neoplasms | 1 | 2019 | 714 | 0.100 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2022 | 3782 | 0.100 |
Why?
|
Pancreatitis | 1 | 2019 | 1087 | 0.100 |
Why?
|
Neoadjuvant Therapy | 1 | 2023 | 2907 | 0.100 |
Why?
|
Embolism | 1 | 2015 | 401 | 0.100 |
Why?
|
Injury Severity Score | 1 | 2015 | 1049 | 0.100 |
Why?
|
Natural Language Processing | 1 | 2021 | 1203 | 0.100 |
Why?
|
Fetus | 1 | 2019 | 1883 | 0.100 |
Why?
|
Lung Diseases, Interstitial | 1 | 2020 | 940 | 0.090 |
Why?
|
Consensus | 1 | 2021 | 3211 | 0.090 |
Why?
|
Neoplasms, Second Primary | 1 | 2019 | 1061 | 0.090 |
Why?
|
Endocarditis | 1 | 2015 | 352 | 0.090 |
Why?
|
Tumor Burden | 1 | 2017 | 1906 | 0.090 |
Why?
|
Education, Medical, Continuing | 1 | 2016 | 829 | 0.090 |
Why?
|
Time Factors | 2 | 2023 | 40220 | 0.090 |
Why?
|
Education, Medical, Graduate | 1 | 2022 | 2420 | 0.090 |
Why?
|
Syndrome | 1 | 2016 | 3273 | 0.080 |
Why?
|
Calcium | 1 | 2022 | 5792 | 0.080 |
Why?
|
Child, Preschool | 3 | 2022 | 42669 | 0.080 |
Why?
|
Pericardium | 1 | 2013 | 679 | 0.080 |
Why?
|
Chronic Disease | 1 | 2024 | 9384 | 0.080 |
Why?
|
Cooperative Behavior | 1 | 2016 | 1514 | 0.080 |
Why?
|
Breast Neoplasms | 1 | 2016 | 21207 | 0.080 |
Why?
|
Societies, Medical | 1 | 2021 | 3968 | 0.080 |
Why?
|
Radiographic Image Enhancement | 1 | 2013 | 877 | 0.080 |
Why?
|
Incidence | 2 | 2024 | 21538 | 0.080 |
Why?
|
Aorta, Thoracic | 1 | 2015 | 1112 | 0.080 |
Why?
|
Mannose-Binding Lectin | 1 | 2009 | 146 | 0.080 |
Why?
|
Boston | 1 | 2020 | 9374 | 0.070 |
Why?
|
Age Factors | 1 | 2024 | 18415 | 0.070 |
Why?
|
Autoimmune Diseases | 1 | 2019 | 2257 | 0.070 |
Why?
|
Chest Pain | 1 | 2013 | 1101 | 0.070 |
Why?
|
Thrombosis | 1 | 2020 | 2957 | 0.070 |
Why?
|
Adenocarcinoma | 1 | 2023 | 6395 | 0.060 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2019 | 3390 | 0.060 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2009 | 549 | 0.060 |
Why?
|
Quality Improvement | 1 | 2020 | 3857 | 0.060 |
Why?
|
Neoplasm Staging | 1 | 2020 | 11244 | 0.060 |
Why?
|
Lymphocyte Transfusion | 1 | 2006 | 232 | 0.060 |
Why?
|
Anticoagulants | 1 | 2021 | 4850 | 0.060 |
Why?
|
Biopsy | 1 | 2017 | 6792 | 0.060 |
Why?
|
Pulmonary Artery | 2 | 2024 | 1946 | 0.060 |
Why?
|
Arthritis, Rheumatoid | 1 | 2020 | 3781 | 0.060 |
Why?
|
Transplantation Immunology | 1 | 2006 | 537 | 0.060 |
Why?
|
Models, Statistical | 1 | 2018 | 5107 | 0.060 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2019 | 4058 | 0.050 |
Why?
|
Prognosis | 1 | 2024 | 30009 | 0.050 |
Why?
|
Electronic Health Records | 1 | 2021 | 4887 | 0.050 |
Why?
|
Cohort Studies | 3 | 2020 | 41753 | 0.050 |
Why?
|
Child | 2 | 2021 | 80917 | 0.050 |
Why?
|
Databases, Factual | 1 | 2016 | 8080 | 0.040 |
Why?
|
Herpesvirus 4, Human | 1 | 2006 | 1082 | 0.040 |
Why?
|
Pulmonary Alveoli | 1 | 2023 | 665 | 0.040 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2023 | 465 | 0.040 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2006 | 1801 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2016 | 22290 | 0.040 |
Why?
|
Communication | 2 | 2023 | 3905 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2020 | 13677 | 0.040 |
Why?
|
Pregnancy | 1 | 2019 | 30255 | 0.030 |
Why?
|
Respiratory System | 1 | 2020 | 564 | 0.030 |
Why?
|
Autopsy | 1 | 2020 | 1011 | 0.030 |
Why?
|
Radiology Information Systems | 1 | 2021 | 533 | 0.030 |
Why?
|
Thorax | 1 | 2019 | 557 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2023 | 65379 | 0.030 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 747 | 0.030 |
Why?
|
Aftercare | 1 | 2020 | 916 | 0.030 |
Why?
|
Aortography | 1 | 2015 | 422 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 4585 | 0.030 |
Why?
|
Graft Rejection | 1 | 2006 | 4492 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2020 | 3620 | 0.020 |
Why?
|
United States | 1 | 2020 | 73039 | 0.020 |
Why?
|
Vaccination | 1 | 2022 | 3437 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2020 | 8542 | 0.020 |
Why?
|
Kidney | 1 | 2023 | 7064 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2023 | 6669 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2020 | 3533 | 0.020 |
Why?
|
Disease Progression | 1 | 2023 | 13668 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2023 | 9419 | 0.010 |
Why?
|
Antigens, Viral | 1 | 2006 | 995 | 0.010 |
Why?
|
Transplantation, Autologous | 1 | 2006 | 2125 | 0.010 |
Why?
|
Endovascular Procedures | 1 | 2015 | 2217 | 0.010 |
Why?
|
Recurrence | 1 | 2009 | 8509 | 0.010 |
Why?
|
Infant | 1 | 2006 | 36535 | 0.000 |
Why?
|